Alzamend Neuro (ALZN) Total Current Liabilities (2020 - 2024)

Alzamend Neuro has disclosed Total Current Liabilities across 5 years of filings, most recently posting $3.8 million for Q1 2024.

• In Q1 2024, Total Current Liabilities rose 44.81% year-over-year to $3.8 million; the TTM figure through Jan 2024 stood at $3.8 million (up 44.81% YoY), while the FY2023 annual figure was $2.9 million, up 146.38% from the prior year.
• Total Current Liabilities came in at $3.8 million for Q1 2024 at Alzamend Neuro, up from $2.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $3.8 million in Q1 2024 to a low of $466977.0 in Q1 2022.
• Average Total Current Liabilities over 5 years is $1.7 million, with a median of $1.5 million recorded in 2021.
• Year-over-year, Total Current Liabilities sank 30.18% in 2022 and soared 465.87% in 2023.
• Over 5 years, Total Current Liabilities stood at $992306.0 in 2020, then surged by 48.69% to $1.5 million in 2021, then gained by 10.98% to $1.6 million in 2022, then surged by 75.28% to $2.9 million in 2023, then surged by 33.32% to $3.8 million in 2024.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $3.8 million in Q1 2024, $2.9 million in Q2 2023, and $2.6 million in Q1 2023.